BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27023103)

  • 1. Accurate prediction tools in prostate cancer require consistent assessment of included variables.
    Jäderling F; Nyberg T; Blomqvist L; Bjartell A; Steineck G; Carlsson S
    Scand J Urol; 2016 Aug; 50(4):260-6. PubMed ID: 27023103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series.
    Tosco L; De Coster G; Roumeguère T; Everaerts W; Quackels T; Dekuyper P; Van Cleynenbreugel B; Van Damme N; Van Eycken E; Ameye F; Joniau S;
    Eur Urol Oncol; 2018 Sep; 1(4):338-345. PubMed ID: 31100256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.
    Jeong CW; Jeong SJ; Hong SK; Lee SB; Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE
    Int J Urol; 2012 Sep; 19(9):846-52. PubMed ID: 22587373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
    Zorn KC; Capitanio U; Jeldres C; Arjane P; Perrotte P; Shariat SF; Lee DI; Shalhav AL; Zagaja GP; Shikanov SA; Gofrit ON; Thong AE; Albala DM; Sun L; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1461-7. PubMed ID: 18938046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy.
    Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde HVN; Biesma DH; Witjes JA; van Basten JA
    Urol Oncol; 2020 May; 38(5):372-378. PubMed ID: 32088104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
    Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of nomogram predicting the probability of specimen-confined disease (pT2-3a, R0N0) in patients undergoing radical prostatectomy and pelvic lymph node dissection.
    Mearini L; Gacci M; Saleh O; De Nunzio C; Schiavina R; Simonato A; Tubaro A; Carmignani G; Mirone V; Carini M; Bini V; Porena M;
    Urol Int; 2014; 93(3):262-8. PubMed ID: 24356093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the partin nomogram for prostate cancer in a national sample.
    Yu JB; Makarov DV; Sharma R; Peschel RE; Partin AW; Gross CP
    J Urol; 2010 Jan; 183(1):105-11. PubMed ID: 19913246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer.
    Borque Á; Rubio-Briones J; Esteban LM; Sanz G; Domínguez-Escrig J; Ramírez-Backhaus M; Calatrava A; Solsona E
    BJU Int; 2014 Jun; 113(6):878-86. PubMed ID: 24529282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Head to head comparison of two currently used nomograms predicting the risk of side specific extra capsular extension to indicate nerve sparing during radical prostatectomy for treatment of prostate cancer].
    Clement C; Maurin C; Villeret J; Marcy M; Salem N; Brunelle S; Gravis G; Garcia S; Giusiano S; Bastide C; Rossi D; Bladou F; Walz J
    Prog Urol; 2014 Jul; 24(9):581-7. PubMed ID: 24975793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation.
    Hansen J; Becker A; Kluth LA; Rink M; Steuber T; Zacharias M; Briganti A; Fisch M; Graefen M; Chun FK
    Urol Oncol; 2015 Sep; 33(9):384.e1-8. PubMed ID: 26122714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
    Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
    Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.
    Kattan MW; Yu C; Salomon L; Vora K; Touijer K; Guillonneau B
    Urology; 2011 Feb; 77(2):396-401. PubMed ID: 20970840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
    Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
    Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
    Penson DF; Grossfeld GD; Li YP; Henning JM; Lubeck DP; Carroll PR
    J Urol; 2002 Apr; 167(4):1653-7; discussion 1657-8. PubMed ID: 11912382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.